(Q81087251)
Statements
Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose (English)
Joseph G Rajendran
Darrel R Fisher
Larry D Durack
1 reference